NDC 24275-0185-01 - Fludeoxyglucose F18
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 24275-0185
- Requested NDC
- 24275-0185-01
- Package NDCs from labels
- 24275-0185-1, 24275-0185-01
- Manufacturer
- UCSF Radiopharmaceutical Facility
- Effective date
- 2025-11-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Fludeoxyglucose F18 - UCSF Radiopharmaceutical Facility | UCSF Radiopharmaceutical Facility | 2025-11-14 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 24275-0185-1 | Fludeoxyglucose F18 | 17 mL in 1 VIAL, GLASS | INJECTION | 17 | 18 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 24275-0185 | FLUDEOXYGLUCOSE F18 INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 17 | Current NDC, Legacy NDC, 1 package rows | 20241013_763958a2-6952-4c0d-8a4a-9c04acb62229.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| FLUDEOXYGLUCOSE F-18 | ACTIVE INGREDIENT | 0Z5B2CJX4D | FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 9 | |
| FLUDEOXYGLUCOSE F-18 | ACTIVE MOIETY | 0Z5B2CJX4D | FLUDEOXYGLUCOSE F18 (FLUDEOXYGLUCOSE F18) INJECTION [UCSF RADIOPHARMACEUTICAL FACILITY] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Fludeoxyglucose F-18 | FLUDEOXYGLUCOSE F-18 | Precision Nuclear, LLC | 09ae2a6d-673a-423a-ba45-3c543061b103 | 2026-07-09 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F-18 | Biomedical Research Foundation of Northwest Louisiana | edb15e3c-848d-433d-9f1c-c73a3c72861b | 2026-06-10 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | Biomedical Research Foundation of Northwest Louisiana | 1deaaa92-1c98-4295-8aa6-7a70bc29f55d | 2026-06-10 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F 18 | PETNET Solutions, Inc. | caaa9ab5-e3f4-489d-9f4c-0ecbee6fca83 | 2026-03-31 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | Kreitchman PET Center | 1e415eb3-e8a5-4149-b4ec-ba9ab3b29d7f | 2026-01-27 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | Jubilant DraxImage Inc., dba Jubilant Radiopharma | 5d05df4a-463e-4e66-9387-f3a842e20cd0 | 2026-01-27 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | Kettering Medical Center | 982b9df4-0772-4de1-a01e-794a77518500 | 2026-01-09 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | 3D Imaging Drug Design and Development LLC | 2785ce60-86c9-42c2-ab0a-8c5d5adf60d3 | 2025-12-31 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | Mayo Clinic | 153b650d-7b69-4880-a72a-a5f13059d248 | 2025-12-26 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | SOFIE Co. | 2028be0c-333c-4e0c-be57-099276c725d7 | 2025-11-19 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | UCSF Radiopharmaceutical Facility | 763958a2-6952-4c0d-8a4a-9c04acb62229 | 2025-11-14 | Warnings, Adverse reactions | ANDA203902 24275-0185-1 24275-0185 24275018501 4395a8f3-f48b-e90c-e063-6294a90a7ae5 763958a2-6952-4c0d-8a4a-9c04acb62229 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | The Regents of the University of Michigan | 35bfa064-4313-49e2-98d2-85a84d2c40a4 | 2025-10-14 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | The University of Texas MD Anderson Cancer Center | 43954e40-bb95-4275-92ab-96211b7de907 | 2025-10-03 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F 18 | SOFIE Co. dba SOFIE | 915b1f71-616d-4cd9-90a7-bc556736a3d1 | 2025-04-30 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F-18 | BAMF Health Inc. | 347c6beb-499e-af61-e063-6394a90a6011 | 2025-03-11 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F18 | FLUDEOXYGLUCOSE F18 | MIPS Cyclotron & Radiochemistry Facility | 0ec2d4d1-b295-18dc-e054-00144ff88e88 | 2025-01-14 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F-18 | FLUDEOXYGLUCOSE F-18 | Trustees of the University of Pennsylvania | 84f1aeab-685d-47fd-a8e9-e724979c4ce6 | 2025-01-09 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| FLUDEOXYGLUCOSE F-18 | FLUDEOXYGLUCOSE F-18 | Barbara Ann Karmanos Cancer Hospital | e3791140-2e52-48c5-9849-536d5e4275e5 | 2022-11-10 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| FLUDEOXYGLUCOSE F 18 | FLUDEOXYGLUCOSE F-18 | UIHC-P E T IMAGING CENTER | 4842b836-1a7c-4417-ab8d-aa37bf7065f8 | 2022-10-09 | Warnings, Adverse reactions | 0Z5B2CJX4D |
| Fludeoxyglucose F 18 | FLUDEOXYGLUCOSE F 18 | The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute | 4439286d-2b7b-4403-9e4a-3b0aad10ad5b | 2022-03-02 | Warnings, Adverse reactions | 0Z5B2CJX4D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.